Luye Claims A First With Chinese Denosumab Approval

Boan Biotech Subsidiary Sees Prolia Biosimilar Boyoubei Approved By China’s NMPA

 
• By David Wallace
Prolia pack injector
Luye’s biosimilar version of Prolia has been approved in China • Source: Shutterstock

More from Biosimilars

More from Products